Skip to content

Clinical trials

Phase 1 Lymphoma, Non-Hodgkin trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 1 Clear all

698 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200015
200111
200213
200312
200423
200512
200621
200732
200826
200924
201018
201127
201219
201327
201421
201517
201624
201730
201827
201929
202037
202130
202239
202335
202422
202522
202620

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed371
Terminated121
Recruiting69
Active, not recruiting52
Unknown status48
Withdrawn26
Not yet recruiting9
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)67
Baylor College of Medicine24
Memorial Sloan Kettering Cancer Center16
AbbVie15
M.D. Anderson Cancer Center13
Janssen Research & Development, LLC12
Case Comprehensive Cancer Center10
Celgene10
City of Hope Medical Center9
Genentech, Inc.9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin698
Leukemia, Lymphocytic, Chronic, B-Cell275
Lymphoma, Large B-Cell, Diffuse240
Lymphoma, Follicular237
Precursor Cell Lymphoblastic Leukemia-Lymphoma237
Hodgkin Disease229
Lymphoma, Mantle-Cell217
Lymphoma209
Lymphoma, B-Cell, Marginal Zone195
Burkitt Lymphoma179

Trials

Showing 76 to 100 of 698. Each trial links to its page on Pharma Observatory.

598 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.